Your search returned 23 results.

Results
	21.	Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC. [electronic resource] by Ou, S-H I Jänne, P A Bartlett, C H Tang, Y Kim, D-W Otterson, G A Crinò, L Selaru, P Cohen, D P Clark, J W Riely, G J Producer: 20150330 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. [electronic resource] by Layman, L C Cohen, D P Jin, M Xie, J Li, Z Reindollar, R H Bolbolan, S Bick, D P Sherins, R R Duck, L W Musgrove, L C Sellers, J C Neill, J D Producer: 19980129 In: Nature genetics vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure. [electronic resource] by George, S Blay, J Y Casali, P G Le Cesne, A Stephenson, P Deprimo, S E Harmon, C S Law, C N J Morgan, J A Ray-Coquard, I Tassell, V Cohen, D P Demetri, G D Producer: 20090811 In: European journal of cancer (Oxford, England : 1990) vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)